Smaller Indian Drug Makers Seek Help To Defend Against Takeovers
This article was originally published in PharmAsia News
Executive SummaryIndia's smaller drug makers plan to seek government protection from acquisition efforts by multinational pharmaceutical companies
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.